Mizuho Medy Co Ltd
TSE:4595

Watchlist Manager
Mizuho Medy Co Ltd Logo
Mizuho Medy Co Ltd
TSE:4595
Watchlist
Price: 2 289 JPY -0.82% Market Closed
Market Cap: 34.4B JPY
Have any thoughts about
Mizuho Medy Co Ltd?
Write Note

Mizuho Medy Co Ltd
Accounts Payable

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Mizuho Medy Co Ltd
Accounts Payable Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Accounts Payable CAGR 3Y CAGR 5Y CAGR 10Y
Mizuho Medy Co Ltd
TSE:4595
Accounts Payable
ÂĄ600m
CAGR 3-Years
12%
CAGR 5-Years
14%
CAGR 10-Years
N/A
Terumo Corp
TSE:4543
Accounts Payable
ÂĄ94B
CAGR 3-Years
9%
CAGR 5-Years
4%
CAGR 10-Years
10%
Olympus Corp
TSE:7733
Accounts Payable
ÂĄ57.9B
CAGR 3-Years
3%
CAGR 5-Years
1%
CAGR 10-Years
3%
Sysmex Corp
TSE:6869
Accounts Payable
ÂĄ27.4B
CAGR 3-Years
-7%
CAGR 5-Years
0%
CAGR 10-Years
6%
Nihon Kohden Corp
TSE:6849
Accounts Payable
ÂĄ17.7B
CAGR 3-Years
-4%
CAGR 5-Years
-7%
CAGR 10-Years
-2%
JEOL Ltd
TSE:6951
Accounts Payable
ÂĄ26.7B
CAGR 3-Years
6%
CAGR 5-Years
3%
CAGR 10-Years
5%
No Stocks Found

Mizuho Medy Co Ltd
Glance View

Market Cap
34.4B JPY
Industry
Health Care

Mizuho Medy Co., Ltd. engages in the research, development, manufacture and distribution of in-vitro diagnostic products. The company is headquartered in Tosu-Shi, Saga-Ken and currently employs 173 full-time employees. The company went IPO on 2015-12-17. The firm mainly provides in-vitro diagnostic pharmaceuticals, including immune serum test drugs, biochemical test drugs, urine and feces test drugs, microbial test drugs, blood test drugs, pathological test drugs and others, in hospital and medical practitioner fields. In addition, the Company also provides over-the-counter (OTC) drugs to pharmacies and drug stores, and sells fruit tree virus test drugs to which they apply the technology of immune serology test to agricultural test centers.

Intrinsic Value
2 410.26 JPY
Undervaluation 5%
Intrinsic Value
Price

See Also

What is Mizuho Medy Co Ltd's Accounts Payable?
Accounts Payable
600m JPY

Based on the financial report for Sep 30, 2024, Mizuho Medy Co Ltd's Accounts Payable amounts to 600m JPY.

What is Mizuho Medy Co Ltd's Accounts Payable growth rate?
Accounts Payable CAGR 5Y
14%

Over the last year, the Accounts Payable growth was 20%. The average annual Accounts Payable growth rates for Mizuho Medy Co Ltd have been 12% over the past three years , 14% over the past five years .

Back to Top